Identification of Symptom Clusters Among Midlife Menopausal Women with Metabolic Syndrome

Abstract

The aim of this study was to identify and compare symptom clusters in midlife menopausal women with and without metabolic syndrome based on symptom occurrence and severity dimension through secondary data analysis of the Study of Women’s Health Across the Nation. Exploratory factor analysis was used to group symptoms that are highly correlated with each other and verified by confirmatory factor analysis. Midlife menopausal women with metabolic syndrome (n = 424) experienced mental health, vasomotor, and somatic cluster across both symptom dimensions. In contrast, midlife menopausal women without metabolic syndrome (n = 1022) experienced mental health/sleep/urinary, vasomotor, and somatic cluster for symptom occurrence dimension and mental health/sleep, vasomotor/genital, and somatic cluster for symptom severity dimension. This is the first study to identify symptom clusters in midlife menopausal women with metabolic syndrome, who are at risk for experiencing complex symptoms associated with menopause transition and metabolic syndrome, and to compare symptom clusters to those without metabolic syndrome.

Keywords

Menopause Obesity Quality of life Symptom management Women’s health

Get full access to this article

View all access options for this article.

References

Albusoul

R. M.

Berger

A. M.

Gay

C. L.

Janson

S. L.

Lee

K. A.

(2017). Symptom clusters change over time in women receiving adjuvant chemotherapy for breast cancer. Journal of Pain and Symptom Management, 53(5), 880–886. https://doi.org/10.1016/j.jpainsymman.2016.12.332

Almutary

Douglas

Bonner

(2016). Multidimensional symptom clusters: An exploratory factor analysis in advanced chronic kidney disease. Journal of Advanced Nursing, 72(10), 2389–2400. https://doi.org/10.1111/jan.12997

Augoulea

Moros

Lykeridou

Kaparos

Lyberi

Panoulis

(2019). Psychosomatic and vasomotor symptom changes during transition to menopause. Przeglad Menopauzalny = Menopause Review, 18(2), 110–115. https://doi.org/10.5114/pm.2019.86835

Avis

N. E.

Crawford

S. L.

Green

(2018). Vasomotor symptoms across the menopause transition: Differences among women. Obstetrics and Gynecology Clinics of North America, 45(4), 629–640. https://doi.org/10.1016/j.ogc.2018.07.005

Baggott

Cooper

B. A.

Marina

Matthay

K. K.

Miaskowski

(2012). Symptom cluster analyses based on symptom occurrence and severity ratings among pediatric oncology patients during myelosuppressive chemotherapy. Cancer Nursing, 35(1), 19–28. https://doi.org/10.1097/NCC.0b013e31822909fd

Barsevick

A. M.

Whitmer

Nail

L. M.

Beck

S. L.

Dudley

W. N.

(2006). Symptom cluster research: Conceptual, design, measurement, and analysis issues. Journal of Pain and Symptom Management, 31(1), 85–95. https://doi.org/10.1016/j.jpainsymman.2005.05.015

Beigh

S. H.

Jain

(2012). Prevalence of metabolic syndrome and gender differences. Bioinformation, 8(13), 613–616. https://doi.org/10.6026/97320630008613

Blümel

J. E.

Chedraui

Baron

Belzares

Bencosme

Calle

Danckers

Espinoza

M. T.

Flores

Gomez

Hernandez-Bueno

J. A.

Izaguirre

Leon-Leon

Lima

Mezones-Holguin

Monterrosa

Mostajo

Navarro

Ojeda

, . . . Collaborative Group for Research of the Climacteric in Latin America (REDLINC). (2011). A large multinational study of vasomotor symptom prevalence, duration, and impact on quality of life in middle-aged women. Menopause, 18(7), 778–785. https://doi.org/10.1097/gme.0b013e318207851d

Bromberger

J. T.

Kravitz

H. M.

Chang

Randolph

J. F.

Avis

N. E.

Gold

E. B.

Matthews

K. A.

(2013). Does risk for anxiety increase during the menopausal transition? Study of Women’s Health Across the Nation (SWAN). Menopause, 20(5), 488–495. https://doi.org/10.1097/GME.0b013e3182730599

10.

Burrell

S. A.

Yeo

T. P.

Smeltzer

S. C.

Leiby

B. E.

Lavu

Kennedy

E. P.

Yeo

C. J.

(2018). Symptom clusters in patients with pancreatic cancer undergoing surgical resection: Part I. Oncology Nursing Forum, 45(4), E36–E52. https://doi.org/10.1188/18.ONF.E36-E52

11.

Cheng

Lin

Cao

Liao

Mou

Zhang

Liu

(2020). Association of urinary incontinence and depression or anxiety: A meta-analysis. The Journal of International Medical Research, 48(6), 300060520931348. https://doi.org/10.1177/0300060520931348

12.

Christakis

M. K.

Hasan

De Souza

L. R.

Shirreff

(2020). The effect of menopause on metabolic syndrome: Cross-sectional results from the Canadian Longitudinal Study on Aging. Menopause, 27(9), 999–1009. https://doi.org/10.1097/GME.0000000000001575

13.

Cosco

T. D.

Prina

Stubbs

Y. T.

(2017). Reliability and validity of the center for epidemiologic studies depression scale in a population-based cohort of middle-aged U.S. adults. Journal of Nursing Measurement, 25(3), 476–485. https://doi.org/10.1891/1061-3749.25.3.476

14.

Debelak

Tran

U. S.

(2016). Comparing the effects of different smoothing algorithms on the assessment of dimensionality of ordered categorical items with parallel analysis. PLoS One, 11(2), e0148143. https://doi.org/10.1371/journal.pone.0148143

15.

Delamater

Santoro

(2018). Management of the perimenopause. Clinical Obstetrics and Gynecology, 61(3), 419–432. https://doi.org/10.1097/GRF.0000000000000389

16.

Dutra da Silva

G. M.

Rolim Rosa Lima

S. M.

Reis

B. F.

Macruz

C. F.

Postigo

(2020). Prevalence of hypoactive sexual desire disorder among sexually active postmenopausal women with metabolic syndrome at a public hospital clinic in Brazil: A cross-sectional study. Sexual Medicine, 8(3), 545–553. https://doi.org/10.1016/j.esxm.2020.05.008

17.

El Khoudary

S. R.

Greendale

Crawford

S. L.

Avis

N. E.

Brooks

M. M.

Thurston

R. C.

Karvonen-Gutierrez

Waetjen

L. E.

Matthews

. (2019). The menopause transition and women’s health at midlife: A progress report from the Study of Women’s Health Across the Nation (SWAN). Menopause, 26(10), 1213–1227. https://doi.org/10.1097/GME.0000000000001424

18.

Erbil

(2018). Attitudes towards menopause and depression, body image of women during menopause. Alexandria Journal of Medicine, 54(3), 241–246. https://doi.org/10.1016/j.ajme.2017.05.012

19.

Farrell Am

. (2017). Genitourinary syndrome of menopause. Australian Family Physician, 46(7), 481–484.

20.

Gracia

C. R.

Freeman

E. W.

(2018). Onset of the menopause transition: The earliest signs and symptoms. Obstetrics and Gynecology Clinics of North America, 45(4), 585–597. https://doi.org/10.1016/j.ogc.2018.07.002

21.

Guicciardi

Crisafulli

Doneddu

Fadda

Lecis

(2019). Effects of metabolic syndrome on cognitive performance of adults during exercise. Frontiers in Psychology, 10, 1845. https://doi.org/10.3389/fpsyg.2019.01845

22.

Gurka

M. J.

Filipp

S. L.

DeBoer

M. D.

(2018). Geographical variation in the prevalence of obesity, metabolic syndrome, and diabetes among US adults. Nutrition & Diabetes, 8(1), 14. https://doi.org/10.1038/s41387-018-0024-2

23.

Hair

(2009). Multivariate data analysis. Faculty Publications. https://digitalcommons.kennesaw.edu/facpubs/2925

24.

Hall

M. H.

Okun

M. L.

Sowers

Matthews

K. A.

Kravitz

H. M.

Hardin

Buysse

D. J.

Bromberger

J. T.

Owens

J. F.

Karpov

Sanders

M. H.

(2012). Sleep is associated with the metabolic syndrome in a multi-ethnic cohort of midlife women: The SWAN sleep study. Sleep, 35(6), 783–790. https://doi.org/10.5665/sleep.1874

25.

Jablonski

(2007). The multidimensional characteristics of symptoms reported by patients on hemodialysis. Nephrology Nursing Journal, 34(1), 29–37.

26.

Jackson

E. A.

El Khoudary

S. R.

Crawford

S. L.

Matthews

Joffe

Chae

Thurston

R. C.

(2016). Hot flash frequency and blood pressure: Data from the Study of Women’s Health Across the Nation. Journal of Women’s Health, 25(12), 1204–1209. https://doi.org/10.1089/jwh.2015.5670

27.

Jafari

Hadizadeh

M. H.

Zabihi

Ganji

(2014). Comparison of depression, anxiety, quality of life, vitality and mental health between premenopausal and postmenopausal women. Climacteric: The Journal of the International Menopause Society, 17(6), 660–665. https://doi.org/10.3109/13697137.2014.905528

28.

Jehan

Masters-Isarilov

Salifu

Zizi

Jean-Louis

Pandi-Perumal

S. R.

Gupta

Brzezinski

McFarlane

S. I.

(2015). Sleep disorders in postmenopausal women. Journal of Sleep Disorders and Therapy, 4(5), 212.

29.

Jouyandeh

Nayebzadeh

Qorbani

Asadi

(2013). Metabolic syndrome and menopause. Journal of Diabetes and Metabolic Disorders, 12(1), 1. https://doi.org/10.1186/2251-6581-12-1

30.

Kahyaoglu Sut

Sut

. (2017). Severity of menopausal symptoms in climacteric Turkish women. International Journal of Caring Sciences, 10(1), 1–383.

31.

Kim

C. E.

Shin

Lee

H. W.

Lim

Lee

Shin

Kang

(2018). Association between sleep duration and metabolic syndrome: A cross-sectional study. BMC Public Health, 18(1), 720. https://doi.org/10.1186/s12889-018-5557-8

32.

Kim

H. J.

(2008). Common factor analysis versus principal component analysis: Choice for symptom cluster research. Asian Nursing Research, 2(1), 17–24. https://doi.org/10.1016/S1976-1317(08)60025-0

33.

Kim

S. A.

Jung

(2015). Prevention of cognitive impairment in the midlife women. Journal of Menopausal Medicine, 21(1), 19–23. https://doi.org/10.6118/jmm.2015.21.1.19

34.

Kravitz

H. M.

Schott

L. L.

Joffe

Cyranowski

J. M.

Bromberger

J. T.

(2014). Do anxiety symptoms predict major depressive disorder in midlife women? The Study of Women’s Health Across the Nation (SWAN) Mental Health Study (MHS). Psychological Medicine, 44(12), 2593–2602. https://doi.org/10.1017/S0033291714000075

35.

Lampio

Polo-Kantola

Polo

Kauko

Aittokallio

Saaresranta

(2014). Sleep in midlife women: Effects of menopause, vasomotor symptoms, and depressive symptoms. Menopause, 21(11), 1217–1224. https://doi.org/10.1097/GME.0000000000000239

36.

Lee

S. W.

H. H.

Kim

M. R.

Kwon

D. J.

You

Y. O.

Kim

J. H.

(2012). Association between menopausal symptoms and metabolic syndrome in postmenopausal women. Archives of Gynecology and Obstetrics, 285(2), 541–548. https://doi.org/10.1007/s00404-011-2016-5

37.

Mäntyselkä

Kautiainen

Vanhala

(2010). Prevalence of neck pain in subjects with metabolic syndrome—A cross-sectional population-based study. BMC Musculoskeletal Disorders, 11, 171. https://doi.org/10.1186/1471-2474-11-171

38.

Marazziti

Rutigliano

Baroni

Landi

Dell’Osso

(2014). Metabolic syndrome and major depression. CNS Spectrums, 19(4), 293–304. https://doi.org/10.1017/S1092852913000667

39.

Marchi

de, Dell’Agnolo

C. M.

Lopes

T. C. R.

Gravena

A. A. F.

Demitto

M. de O.

Brischiliari

S. C. R.

Borghesan

D. H. P.

Carvalho

M. D. de B.

Pelloso

S. M.

Marchi

Dell’Agnolo C. M.

Lopes

T. C. R.

Gravena

A. A. F.

Demitto

M. de O.

Brischiliari

S. C. R.

Borghesan

D. H. P.

Carvalho

M. D. de B.

Pelloso

S. M.

(2017). Prevalence of metabolic syndrome in pre- and postmenopausal women. Archives of Endocrinology and Metabolism, 61(2), 160–166. https://doi.org/10.1590/2359-3997000000253

40.

McWilliams

L. A.

Goodwin

R. D.

Cox

B. J.

(2004). Depression and anxiety associated with three pain conditions: Results from a nationally representative sample. Pain, 111(1–2), 77–83. https://doi.org/10.1016/j.pain.2004.06.002

41.

Mendrick

D. L.

Diehl

A. M.

Topor

L. S.

Dietert

R. R.

Will

La Merrill

M. A.

Bouret

Varma

Hastings

K. L.

Schug

T. T.

Emeigh Hart

S. G.

Burleson

F. G.

(2018). Metabolic syndrome and associated diseases: From the bench to the clinic. Toxicological Sciences, 162(1), 36–42. https://doi.org/10.1093/toxsci/kfx233

42.

Miaskowski

Barsevick

Berger

Casagrande

Grady

P. A.

Jacobsen

Kutner

Patrick

Zimmerman

Xiao

Matocha

Marden

(2017). Advancing symptom science through symptom cluster research: Expert panel proceedings and recommendations. Journal of the National Cancer Institute, 109(4), djw253. https://doi.org/10.1093/jnci/djw253

43.

Monteleone

Mascagni

Giannini

Genazzani

A. R.

Simoncini

(2018). Symptoms of menopause—Global prevalence, physiology and implications. Nature Reviews. Endocrinology, 14(4), 199–215. https://doi.org/10.1038/nrendo.2017.180

44.

Moral

Delgado

J. L.

Carmona

Caballero

Guillán

González

P. M.

Suárez-Almarza

Velasco-Ortega

Nieto Magro

, & writing group of GENISSE study. (2018). The impact of genitourinary syndrome of menopause on well-being, functioning, and quality of life in postmenopausal women. Menopause, 25(12), 1418–1423. https://doi.org/10.1097/GME.0000000000001148

45.

Orcan

(2018). Exploratory and confirmatory factor analysis: Which one to use first? Journal of Measurement and Evaluation in Education and Psychology, 9(4), 414–421. https://doi.org/10.21031/epod.394323

46.

Repousi

Masana

M. F.

Sanchez-Niubo

Haro

J. M.

Tyrovolas

(2018). Depression and metabolic syndrome in the older population: A review of evidence. Journal of Affective Disorders, 237, 56–64. https://doi.org/10.1016/j.jad.2018.04.102

47.

Rochlani

Pothineni

N. V.

Kovelamudi

Mehta

J. L.

(2017). Metabolic syndrome: Pathophysiology, management, and modulation by natural compounds. Therapeutic Advances in Cardiovascular Disease, 11(8), 215–225. https://doi.org/10.1177/1753944717711379

48.

Ryu

K. J.

Park

H. T.

Kwon

D. H.

Yang

K. S.

Kim

Y. J.

K. W.

Shin

J. H.

Hur

J. Y.

Kim

(2015). Vasomotor symptoms and metabolic syndrome in Korean postmenopausal women. Menopause, 22(11), 1239–1245. https://doi.org/10.1097/GME.0000000000000461

49.

Sherman

(2005). Defining the menopausal transition. The American Journal of Medicine, 118( Suppl 12B), 3–7. https://doi.org/10.1016/j.amjmed.2005.11.002

50.

Shoelson

S. E.

Herrero

Naaz

(2007). Obesity, inflammation, and insulin resistance. Gastroenterology, 132(6), 2169–2180. https://doi.org/10.1053/j.gastro.2007.03.059

51.

Skerman

H. M.

Yates

P. M.

Battistutta

(2012). Identification of cancer-related symptom clusters: An empirical comparison of exploratory factor analysis methods. Journal of Pain and Symptom Management, 44(1), 10–22. https://doi.org/10.1016/j.jpainsymman.2011.07.009

52.

Soares

C. N.

(2019). Depression and menopause: An update on current knowledge and clinical management for this critical window. The Medical Clinics of North America, 103(4), 651–667. https://doi.org/10.1016/j.mcna.2019.03.001

53.

Sood

Kuhle

Kapoor

Rullo

Thielen

Frohmader

Mara

Schroeder

Faubion

(2016). A negative view of menopause: Does the type of symptom matter? Climacteric: The Journal of the International Menopause Society, 19(6), 581–587. https://doi.org/10.1080/13697137.2016.1241227

54.

Terauchi

Odai

Hirose

Kato

Akiyoshi

Miyasaka

(2020). Muscle and joint pains in middle-aged women are associated with insomnia and low grip strength: A cross-sectional study. Journal of Psychosomatic Obstetrics and Gynaecology, 41(1), 15–21. https://doi.org/10.1080/0167482X.2018.1530211

55.

Torréns

J. I.

Sutton-Tyrrell

Zhao

Matthews

Brockwell

Sowers

Santoro

(2009). Relative androgen excess during the menopausal transition predicts incident metabolic syndrome in mid-life women: SWAN. Menopause, 16(2), 257–264. https://doi.org/10.1097/gme.0b013e318185e249

56.

Tuomikoski

Savolainen-Peltonen

(2017). Vasomotor symptoms and metabolic syndrome. Maturitas, 97, 61–65. https://doi.org/10.1016/j.maturitas.2016.12.010

57.

Waetjen

L. E.

Feng

W. Y.

Johnson

W. O.

Greendale

G. A.

Sampselle

C. M.

Sternfield

Harlow

S. D.

Gold

E. B.

(2009). Association between menopausal transition stages and developing urinary incontinence. Obstetrics and Gynecology, 114(5), 989–998. https://doi.org/10.1097/AOG.0b013e3181bb531a

58.

Wang

Zhang

Shi

Zhou

Huang

Liu

(2011). Confirmatory factor analysis of posttraumatic stress symptoms assessed by the Impact of Event Scale-Revised in Chinese earthquake victims: Examining factor structure and its stability across sex. Journal of Anxiety Disorders, 25(3), 369–375. https://doi.org/10.1016/j.janxdis.2010.10.011

59.

Watkins

(2018). Exploratory factor analysis: A guide to best practice. Journal of Black Psychology, 44(3), 219–246. https://doi.org/10.1177/0095798418771807

60.

Yamanaka

Fukuda

Shirota

Sawai

Murai

Fujita

Hosoi

(2013). The prevalence and characteristics of metabolic syndrome in patients with vertigo. PLoS One, 8(12). https://doi.org/10.1371/journal.pone.0080176

61.

Yisma

Eshetu

Dessalegn

(2017). Prevalence and severity of menopause symptoms among perimenopausal and postmenopausal women aged 30–49 years in Gulele sub-city of Addis Ababa, Ethiopia. BMC Women’s Health, 17(1), 124. https://doi.org/10.1186/s12905-017-0484-x